Cargando…

Efficient Large-Scale 2D Culture System for Human Induced Pluripotent Stem Cells and Differentiated Cardiomyocytes

Cardiac regenerative therapies utilizing human induced pluripotent stem cells (hiPSCs) are hampered by ineffective large-scale culture. hiPSCs were cultured in multilayer culture plates (CPs) with active gas ventilation (AGV), resulting in stable proliferation and pluripotency. Seeding of 1 × 10(6)...

Descripción completa

Detalles Bibliográficos
Autores principales: Tohyama, Shugo, Fujita, Jun, Fujita, Chihana, Yamaguchi, Miho, Kanaami, Sayaka, Ohno, Rei, Sakamoto, Kazuho, Kodama, Masami, Kurokawa, Junko, Kanazawa, Hideaki, Seki, Tomohisa, Kishino, Yoshikazu, Okada, Marina, Nakajima, Kazuaki, Tanosaki, Sho, Someya, Shota, Hirano, Akinori, Kawaguchi, Shinji, Kobayashi, Eiji, Fukuda, Keiichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5829307/
https://www.ncbi.nlm.nih.gov/pubmed/28988990
http://dx.doi.org/10.1016/j.stemcr.2017.08.025
Descripción
Sumario:Cardiac regenerative therapies utilizing human induced pluripotent stem cells (hiPSCs) are hampered by ineffective large-scale culture. hiPSCs were cultured in multilayer culture plates (CPs) with active gas ventilation (AGV), resulting in stable proliferation and pluripotency. Seeding of 1 × 10(6) hiPSCs per layer yielded 7.2 × 10(8) hiPSCs in 4-layer CPs and 1.7 × 10(9) hiPSCs in 10-layer CPs with pluripotency. hiPSCs were sequentially differentiated into cardiomyocytes (CMs) in a two-dimensional (2D) differentiation protocol. The efficiency of cardiac differentiation using 10-layer CPs with AGV was 66%–87%. Approximately 6.2–7.0 × 10(8) cells (4-layer) and 1.5–2.8 × 10(9) cells (10-layer) were obtained with AGV. After metabolic purification with glucose- and glutamine-depleted and lactate-supplemented media, a massive amount of purified CMs was prepared. Here, we present a scalable 2D culture system using multilayer CPs with AGV for hiPSC-derived CMs, which will facilitate clinical applications for severe heart failure in the near future.